Screener
Surgery Partners, Inc. SGRY EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Surgery Partners, Inc.’s reported figures.
The source filing: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001638833-26-000046
FAQ
- What is Surgery Partners, Inc.'s EBITDA?
- Surgery Partners, Inc. (SGRY) reported EBITDA of $104.3M in Q1 2026.
- How has Surgery Partners, Inc.'s EBITDA changed year-over-year?
- Surgery Partners, Inc.'s EBITDA increased by 6.2% year-over-year, from $98.2M to $104.3M.
- What is the long-term trend for Surgery Partners, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Surgery Partners, Inc.'s EBITDA has grown at a 9.0% compound annual growth rate (CAGR), from $401M to $565.5M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Surgery Partners, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude